Compare VENUS REMEDIES with TTK HEALTHCARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

VENUS REMEDIES vs TTK HEALTHCARE - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    VENUS REMEDIES TTK HEALTHCARE VENUS REMEDIES/
TTK HEALTHCARE
 
P/E (TTM) x -13.6 10.9 - View Chart
P/BV x 0.9 1.6 57.4% View Chart
Dividend Yield % 0.0 1.0 -  

Financials

 VENUS REMEDIES   TTK HEALTHCARE
EQUITY SHARE DATA
    VENUS REMEDIES
Mar-18
TTK HEALTHCARE
Mar-19
VENUS REMEDIES/
TTK HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs1261,215 10.4%   
Low Rs61610 10.0%   
Sales per share (Unadj.) Rs301.8444.4 67.9%  
Earnings per share (Unadj.) Rs-24.917.2 -144.2%  
Cash flow per share (Unadj.) Rs2.527.6 9.2%  
Dividends per share (Unadj.) Rs05.00 0.0%  
Dividend yield (eoy) %00.5 0.0%  
Book value per share (Unadj.) Rs293.3177.9 164.8%  
Shares outstanding (eoy) m12.3414.13 87.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.32.1 15.1%   
Avg P/E ratio x-3.852.9 -7.1%  
P/CF ratio (eoy) x36.733.0 111.3%  
Price / Book Value ratio x0.35.1 6.2%  
Dividend payout %029.0 0.0%   
Avg Mkt Cap Rs m1,15412,894 8.9%   
No. of employees `0000.92.3 40.0%   
Total wages/salary Rs m3931,307 30.1%   
Avg. sales/employee Rs Th4,026.12,715.7 148.2%   
Avg. wages/employee Rs Th425.0565.3 75.2%   
Avg. net profit/employee Rs Th-331.8105.4 -314.8%   
INCOME DATA
Net Sales Rs m3,7246,279 59.3%  
Other income Rs m2378 29.0%   
Total revenues Rs m3,7476,356 58.9%   
Gross profit Rs m395496 79.7%  
Depreciation Rs m338147 230.6%   
Interest Rs m35434 1,048.2%   
Profit before tax Rs m-275393 -70.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m32149 21.2%   
Profit after tax Rs m-307244 -125.9%  
Gross profit margin %10.67.9 134.3%  
Effective tax rate %-11.537.9 -30.3%   
Net profit margin %-8.23.9 -212.3%  
BALANCE SHEET DATA
Current assets Rs m2,6382,717 97.1%   
Current liabilities Rs m2,3051,571 146.7%   
Net working cap to sales %8.918.3 49.0%  
Current ratio x1.11.7 66.2%  
Inventory Days Days13532 421.2%  
Debtors Days Days4647 99.3%  
Net fixed assets Rs m4,871991 491.5%   
Share capital Rs m123141 87.3%   
"Free" reserves Rs m3,4962,373 147.3%   
Net worth Rs m3,6192,514 143.9%   
Long term debt Rs m1,3743 40,423.5%   
Total assets Rs m7,5094,158 180.6%  
Interest coverage x0.212.6 1.8%   
Debt to equity ratio x0.40 28,083.5%  
Sales to assets ratio x0.51.5 32.8%   
Return on assets %0.66.7 9.5%  
Return on equity %-8.59.7 -87.5%  
Return on capital %1.616.9 9.3%  
Exports to sales %03.6 0.0%   
Imports to sales %13.90.5 2,813.8%   
Exports (fob) Rs mNA225 0.0%   
Imports (cif) Rs m51731 1,668.9%   
Fx inflow Rs m0225 0.0%   
Fx outflow Rs m51771 726.3%   
Net fx Rs m-517154 -335.2%   
CASH FLOW
From Operations Rs m514173 297.2%  
From Investments Rs m-12397 -127.6%  
From Financial Activity Rs m-387-307 126.0%  
Net Cashflow Rs m4-38 -11.1%  

Share Holding

Indian Promoters % 32.9 65.4 50.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.2 3.7 4.9%  
FIIs % 0.6 5.2 11.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 66.4 25.8 257.4%  
Shareholders   20,121 12,723 158.1%  
Pledged promoter(s) holding % 36.4 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare VENUS REMEDIES With:   ELDER PHARMA  FDC  ORCHID PHARMA  DISHMAN PHARMA  FULFORD INDIA  

Compare VENUS REMEDIES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 154 Points Lower, Nifty Ends at 14,834; Bajaj Finance and UPL Among Top Losers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended marginally lower.

Related Views on News

TTK HEALTHCARE Announces Quarterly Results (3QFY21); Net Profit Up 71.7% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, TTK HEALTHCARE has posted a net profit of Rs 77 m (up 71.7% YoY). Sales on the other hand came in at Rs 2 bn (up 8.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (3QFY20); Net Profit Down 8.3% (Quarterly Result Update)

Jan 30, 2020 | Updated on Jan 30, 2020

For the quarter ended December 2019, TTK HEALTHCARE has posted a net profit of Rs 45 m (down 8.3% YoY). Sales on the other hand came in at Rs 2 bn (up 11.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 53.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, TTK HEALTHCARE has posted a net profit of Rs 36 m (down 53.8% YoY). Sales on the other hand came in at Rs 2 bn (up 3.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

TTK HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 38.0% (Quarterly Result Update)

Jun 12, 2019 | Updated on Jun 12, 2019

For the quarter ended March 2019, TTK HEALTHCARE has posted a net profit of Rs 50 m (down 38.0% YoY). Sales on the other hand came in at Rs 1 bn (down 3.8% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

More Views on News

Most Popular

A Critical Update on the Market(Fast Profits Daily)

Mar 30, 2021

In this video, I'll tell you why I am recommending caution in the market at this time.

My Recent Recommendation Will Profit from the Global Supply Chain Crisis(Profit Hunter)

Mar 31, 2021

A tiny chemical company, started in the Licence Raj era, is a great example of a new wealth creating opportunity.

My Stock Trading Strategy(Fast Profits Daily)

Mar 31, 2021

In this video I'll show you exactly how I go about picking stocks for trading.

What You Need to Find Hundred Baggers(Profit Hunter)

Mar 30, 2021

100 baggers of the last decade share this common trait. Here's how to use it to nail future multibaggers.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

VENUS REMEDIES SHARE PRICE


Apr 9, 2021 (Close)

TRACK VENUS REMEDIES

  • Track your investment in VENUS REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON VENUS REMEDIES

VENUS REMEDIES 5-YR ANALYSIS

COMPARE VENUS REMEDIES WITH

MARKET STATS